Contrast-enhanced EUS in differentiating malignant pancreatic cystic neoplasms: evidence should be based on clinical settings
- PMID: 34895617
- DOI: 10.1016/j.gie.2021.08.020
Contrast-enhanced EUS in differentiating malignant pancreatic cystic neoplasms: evidence should be based on clinical settings
Comment in
-
Response.Gastrointest Endosc. 2022 Jan;95(1):201. doi: 10.1016/j.gie.2021.09.034. Gastrointest Endosc. 2022. PMID: 34895619 No abstract available.
Comment on
-
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis.Gastrointest Endosc. 2021 Nov;94(5):881-889.e5. doi: 10.1016/j.gie.2021.06.028. Epub 2021 Jul 1. Gastrointest Endosc. 2021. PMID: 34217751
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
